Shire can’t easily pay more for Baxalta

Pharmaceutical tablets and capsules are arranged in the shape of a U.S. dollar sign on a table in this picture illustration taken in Ljubljana August 20, 2014

Pharmaceutical tablets and capsules are arranged in the shape of a U.S. dollar sign on a table in this picture illustration taken in Ljubljana August 20, 2014

Source: REUTERS/Srdjan Zivulovic

Breakingviews is a subscription service which provides its readers with unique agenda-setting financial insight on the major financial stories 24 hours a day, as they break across the globe. And so keeps them better informed.

Our columnists crunch the numbers, think through the ramifications of events and deliver innovative and hard-hitting perspectives. We produce concise articles that take only a couple of minutes to read, get straight to the point and express a clear view.

Read one of our recent articles

Fake chocolate is a sweeter bet than plant burgers

Email a friend

Plese complete the form below.

14 Aug 2015 | By   Neil Unmack Follow @unmack1
share

The pharma group’s all-stock $75 bln merger approach has been rejected by its rival. Shire’s bid relies on aggressive claims to boost revenue, which Baxalta disputes. Breakingviews’ model shows Shire chief Flemming Ornskov can’t dig much deeper without bold assumptions.

This Content is for
Subscribers only

Sign In

or

Request a Free Trial

Thomson Reuters Products

Westlaw

Build the strongest argument relying on authoritative content, attorney-editor expertise, and industry defining technology.

Onesource

The most comprehensive solution to manage all your complex and ever-expanding tax and compliance needs.

Checkpoint

The industry leader for online information for tax, accounting and finance professionals.


LSEG Products

Workspace

Access unmatched financial data, news and content in a highly-customised workflow experience on desktop, web and mobile.

Data Catalogue

Browse an unrivalled portfolio of real-time and historical market data and insights from worldwide sources and experts.

World-Check

Screen for heightened risk individual and entities globally to help uncover hidden risks in business relationships and human networks.


© Reuters News & Media Ltd 2025. All rights reserved.

This website uses cookies to ensure you get the best experience on our website.  Learn more